Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |